Advertisement
Vaccine maker Novavax will receive $1.6 billion from the U.S. government to provide 100 million doses of a COVID-19 vaccine by early 2021

Company Gets $1.6 Billion From U.S. Government for COVID-19 Vaccine

0
Novavax has never brought a product to market before
Late-stage human trials to assess whether a double antibody cocktail can prevent and treat COVID-19 infection have started

COVID-19 Antibody Cocktail Begins Late-Stage Human Trials

0
Trial will assess whether it can prevent infection among uninfected people in close contact with an infected person
Only a minority of American women have heard of breast implant-associated anaplastic large cell lymphoma and understand its association with breast implants

Most Women Unaware of Breast Implant-Related Lymphoma

0
Even among women with breast implants, just over half have heard of BIA-ALCL
Among low-income adults

Medicaid Expansion Contributing to Earlier Cancer Diagnosis

0
Cancer diagnosis earlier for low-income adults with screening-amenable cancers following Medicaid expansion
A majority of toddlers are being screened for autism spectrum disorder during primary care visits

Most Primary Care Providers Screening Toddlers for Autism

0
Some disparities seen in screening, but screen-positive children diagnosed at younger age
From March 23 to April 23

Incidence of Abusive Head Trauma in Infants May Be Up During Lockdown

0
Abusive head trauma cases increased 1,493 percent compared with previous three years
The majority of individuals using an online COVID-19 self-assessment tool report mild or moderate symptoms possibly associated with COVID-19

Most Using Online COVID-19 Tool Report Mild, Moderate Symptoms

0
Authors say self-assessment tool could ease burden on the health care system, collect useful information
Persons with HIV hospitalized with COVID-19 have similar outcomes to demographically-matched patients without HIV

Outcomes Similar for COVID-19 in Patients With, Without HIV

0
Rate of patients who required mechanical ventilation, died similar for those with HIV, matched comparators
The use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers is associated with lower risk of colorectal cancer risk that develops within three years after index colonoscopy

CRC Risk Down With ACEi, Angiotensin Receptor Blocker Use

0
5 percent reduction in adjusted hazard ratio risk with each single year increase in drug use
The annualized total medical expenditures for asthma and chronic obstructive pulmonary disease are $7 billion and $5 billion among U.S. workers

Health Expenditures Considerable for Asthma, COPD in U.S. Workers

0
Annualized total medical expenditures are $7 billion and $5 billion, respectively